IMI launching project for adaptive Alzheimer's trial

During the G8 Dementia Summit, the EU's Innovative Medicines Initiative (IMI) unveiled a EUR 53 million ($72.7 million) project (EPOC-AD) aimed at developing an adaptive proof-of-concept

Read the full 266 word article

How to gain access

Continue reading with a
two-week free trial.